DESPITE RECENT ADVANCEMENT in pharmacological and surgical interventions to rescue the functional and hibernating myocardium in the ischemic heart, rate of morbidity and mortality in patients with ischemic heart disease remains alarming (1) . Although results from the heart cell therapy with stem cells are promising, the approach suffers from multiple problems, including massive death of the transplanted cells (7) . The present study was designed to reprogram stem cells by treatment with tadalafil, a known cGMP activator that was cardioprotective against ischemic injury.
cGMP is an important intracellular second messenger that mediates multiple tissue and cellular responses, including its role in late-phase preconditioning (4, 10) . Once generated in response to guanylate cyclase activity on GTP, cGMP is stabilized by its association with PKG1 and also stimulates a signal transduction cascade encompassing the activation of cyclic nucleotide-dependent protein kinases (5) . Under physiological conditions, cGMP is inactivated via hydrolytic degradation by phosphodiesterase (PDE). PDEs constitute a superfamily of enzymes with more than 12 PDE gene families, and their isoforms have wide distribution in the body tissues, including the heart (9, 14) . PDE5 is one of three cGMP-specific PDE enzymes besides PDE6 and PDE9 that negatively regulate intracellular cGMP level and its activity (13) . Selectivity of PDE5 enzyme for cGMP therefore makes it an attractive intracellular target to promote cGMP second messenger activity for a required therapeutic outcome. Because cGMP level in the cells is regulated by PDE enzyme activity, PDE inhibitors, which influence cGMP catabolism, will effectively enhance cGMP signaling pathways. PDE5 inhibitors also potentiate a nitric oxide effect to foster cGMP accumulation to restore the PKG signaling pathway (13) .
Tadalafil belongs to the group of long-acting PDE5 inhibitors and protects the ischemic heart for extended time duration (2) . We have already shown that tadalafil administration reduced left ventricular (LV) end-diastolic pressure and increased LV developed pressure besides reducing cardiomyocyte injury through its cytoprotective effects. This protection persisted for 36 h, and a subsequent readministration of tadalafil at 36 and 72 h restored the protection until 108 h, with a possible role of protein kinase B (Akt) signaling (2) . PDE inhibitors have been extensively used for treatment of heart failure, pulmonary hypertension, and coronary artery disease besides their use for the treatment of erectile dysfunction (3, 12, 16, 23) . Inhibition of PDE5 in the hypertrophied myocardium significantly improved myocardial contractility (17) . Unlike previous reports, more recent studies have shown that PDE5A was expressed in the cardiomyocytes, and targeted inhibition of its activity with sildenafil modulated the cardiomyocyte hypertrophy response to phenylephrine treatment in vitro (27) . Extrapolating these observations of cytoprotective effects to the bone marrow-derived mesenchymal stem cells (MSCs), we hypothesized that inhibition of PDE5A activity with tadalafil would promote cGMP/protein kinase G (PKG) activity to condition stem cells for improved survival and proliferation postengraftment in the infarcted heart.
MATERIALS AND METHODS
The concentrations of the reagents used in this study include 100 M H 2O2 (Fisher Scientific), 1 M tadalafil (Eli Lilly), and the PKG inhibitors KT-5823 (1 M; Calbiocam) and K-252a (20 nM; Calbiocam). Isolation, purification, and expansion of MSCs. MSCs were isolated, purified, and cultured from young male Fisher-344 rats using our standard protocol as described earlier (8) . The selection of MSCs was done on the basis of their preferential adherence to the plastic surface followed by flow cytometry, which showed that the purified MSCs were rich in CD44, CD90, and CD29 and low in ckit, CD31 and CD45 expression (8) .
Prevention (group 4) . MSCs were treated with 1 M tadalafil ( Tada MSCs) for 30 min at 37°C in a 5% CO2 atmosphere. For oxidant stress, the cells were exposed to 100 M H 2O2 diluted in serum-and glucose-free DMEM for 4 h at 37°C in a 5% CO 2 atmosphere. The cytoprotective effect of tadalafil treatment was determined by lactate dehydrogenase (LDH) release assay using an LDH Assay Kit (Diagnostic Chemicals) and terminal dUTP nick end-labeling (TUNEL) staining using a commercially available Mebstain Apoptosis Kit II (Medical & Bio Lab) per the instructions of the manufacturer and as described earlier (18) .
Bromodeoxyuridine uptake and cell proliferation. In another set of experiments, both Cont MSCs and Tada MSCs were cultured in the presence of bromodeoxyuridine (BrdU, 50 g/ml culture medium) for 24 h and then immunostained for BrdU uptake. The cells were later washed before immunocytochemistry for BrdU uptake by the replicating DNA in the dividing cells using BrdU-specific antibodies. Cont MSCs without BrdU treatment were used as the negative cellstaining control. Immunodetection of BrdU was carried out using a BrdU in situ detection kit per the instructions of the manufacturer (BD Pharmingen). Briefly, the cells were cultured on chamber slides in fixation buffer for 15 min, washed two times in PBS for 5 min each time, and incubated with diluent buffer for 30 min to permeabilize the cells. After being washed two times in PBS for 5 min, endogenous peroxidase activity was blocked by incubating slides for 10 min in 0.3% H2O2 in PBS. After being rinsed two times in PBS for 5 min and antigen retrieval, the cells were incubated with biotinylated anti-BrdU antibody 1:10 in the diluent buffer for 1 h followed by incubation with streptavidin-horseradish peroxidase for 30 min. Antigen-antibody reaction was detected by adding chromogen diaminobenzidine substrate solution for 5 min until the desired color intensity is developed.
cGMP and PKG activity assays. cGMP activity assay was performed using the cGMP Enzyme Immunoassay Biotrak System (Amersham), which provided a direct competitive immunoassay for sensitive and quantitative determination of cGMP per the instructions of the manufacturer. PKG activity in the cells was measured by using the CycLex Cyclic GMP-dependent protein kinase Assay Kit (catalog no. CY 1161; MBL) per the instructions of the manufacturer.
PKG1 inhibition by adenoviral short-hairpin RNA abolishes tadalafil-induced cytoprotection. Recombinant adenovirus expressing red fluorescent protein as a reporter gene and PKG-short-hairpin RNA (shRNA) or scrambled-shRNA was successfully generated. The following two complementary oligonucleotides of PKG were used: forward, 5=-GATCCGCTATACCGGACATTTAAAGACGAATCTTTAAATG-TCCGGTATAGCTTTTTTG-3=; reverse, 5=-AATTCAAAAAAGCTAT-ACCGGACATTTAAAGATTCGTCTTTAAATGTCCGGTATAGCG-3=. The downstream oligonucleotides were ligated into RNAi-Ready pSIREN-DNR-DsRed-Express Vector. The recombinant plasmid was identified by restriction analysis using the Mlu I restriction site within the shRNA oligonucleotide sequence. The donor vectors were used for Cre-loxP-mediated gene transfer to Adeno-X LP CMV Vector. The colonies were screened for recombinant pLP-Adeno-X DNA by PCR using the Adeno-X LP primers and reconfirmed the identity of the recombinant Adeno PKG plasmid using the restriction analyses (Xho I). Infectious small-interfering RNA adenoviruses were produced by transfecting HEK-293 cells with Pac I-digested pLPAdeno-X DNA. Recombinant adenoviral vectors expressing both red fluorescent protein and PKG shRNA were harvested and purified by CsCl2 gradient centrifugation, and viral titer was determined using our standard protocol. The adenoviral vectors were propagated in HK-293 cells and used for transduction of the cells. MSCs were grown in 6-cm cell culture dishes. At 75-80% confluence, the cells were transduced using adenoviral vector carrying the PKG shRNA gene ( Ad-PKG MSCs). Transduction of the cells was carried out for 6 h on two consecutive days. MSCs transduced with adenoviral scrambled shRNA ( Ad-Sc MSCs) and native nontransduced MSCs were used as controls. The knock down of PKG1 in the cells after 48 h of infection was confirmed by RT-PCR and Western blot compared with adenoviral scrambled shRNA transfected and nontransfected MSCs. These cells were later used for survival studies.
Young female Fischer-344 rats each weighing 180 -200 g were used to develop the heart model of myocardial infarction by permanent ligation of the left anterior descending (LAD) coronary artery as described earlier (24) . Briefly, the animals were anesthetized by intraperitoneal injection of ketamine/xylazine (24 mg/kg and 4 mg/kg body wt, respectively). Subsequent to endotracheal intubation, the animals were mechanically ventilated using a Harvard Apparatus Rodent Ventilator (model 683). The heart was exposed by left-sided minimal thoracotomy. The LAD coronary artery was permanently ligated with Prolene no. 6.0 suture. Immediately after LAD ligation, the animals were grouped to receive injections of 70 l basal DMEM containing 3 ϫ 10 6 Cont MSCs without tadalafil treatment (group 1), Tada MSCs 2 h after drug treatment (group 2), Tada MSCs 24 h after drug treatment (group 3), Tada MSCs 48 h after drug treatment (group 4), and DMEM without cells (group 5). The animals were harvested on day 2 (n ϭ 4/group) and day 4 (n ϭ 4/group) to study the survival of donor cells during the early phase after transplantation and a longer time at 4 wk (n ϭ 8/group in group 1 and group 2) to study the effects on infarct size attenuation and improvement in the indexes of LV contractile function. The animals were killed on their respective time points, and the heart tissues were collected for molecular, histological, and immunohistological studies.
Transthoracic echocardiography for heart function assessment. Transthoracic echocardiography was performed using a Compact Linear Array probe CL10 -5 on HDI-5000 SONOS CT (HP) to determine the indexes of LV heart function 4 wk after cell engraftment (n ϭ 6/group) as described earlier (8) . Anterior and posterior end-diastolic and end-systolic wall thickness and LV internal dimensions [LV end-systolic (LVESD) and end-diastolic (LVEDD) diameters] were measured from at least three consecutive cardiac cycles. Indexes of LV systolic functions, including LV fractional shortening (LVFS) and LV ejection fraction (LVEF), were calculated using the following relations: LVFS ϭ (LVEDD Ϫ LVESD)/LVEDD ϫ 100 and LVEF ϭ [(LVEDD 3 Ϫ LVESD 3 )/LVEDD 3 ] ϫ 100, respectively, and the results were expressed as a percentage.
Quantification for survival of donor cells by real-time PCR. Subsequent to sex-mismatched transplantation of male donor cells, realtime PCR was performed for quantification of sry gene (presence of Y chromosome of the donor male cells) in the female recipient rat heart tissue samples on day 2 and day 4 after cell engraftment (24) . The whole LV tissue specimens were snap-frozen using liquid nitrogen and powdered by grinding the frozen tissue. DNA purification was performed using the genomic DNA Isolation kit (Qiagen), and the concentration of the purified DNA was determined by spectrophotometry. Donor cell survival in the female recipient hearts was determined by real-time PCR using iQ SYBR-Green Supermix (Bio-Rad) in a Bio-Rad iQ5 optical module. The primary curve method was used to calculate the threshold cycle, which was defined as the cycle at which the fluorescence level would reach a predetermined threshold (24) .
Histological studies. For measurement of infarction size, the hearts were arrested in diastole by intravenous injection of cadmium chloride and fixed in 10% buffered formalin. The heart was then excised, cut transversely, and embedded in paraffin. Histological sections of 6 m thickness were cut and used for hematoxylin-eosin and Masson's trichrome staining for visualization of muscle architecture and infarction size measurement. Infarction size (percentage of LV) was defined as the sum of the epicardial and endocardial infarct circumference divided by the sum of the total LV epicardial and endocardial circumferences using computer-based planimetry with Image-J analysis software (version 1.6065; NIH) (8) .
TUNEL assay was performed on deparaffinized 5-m-thick sections using the Mebstain Apoptosis Kit II (Medical & Bio Lab) according to the manufacturer's instructions.
For immunohistological studies to determine the fate of the transplanted cells, the heart tissue specimens were frozen in 100% optimum cutting temperature compound at Ϫ25°C, and 6-to 8-m cryosections were prepared using a cryostat machine (Leica CM-3050S) and transferred on to microscopic glass slides. The tissue sections were dried at 50°C for 2 h and outlined with PapPen before rehydrating with 1ϫ PBS for 15 min. After being blocked with Cas-Block solution (Invitrogen) to prevent nonspecific antigen-antibody reaction, the tissue sections were incubated with primary antibody specific for the antigen of interest to detect the antigen of interest followed by washing in 1ϫ PBS for three times 5 min each. The primary antibodies, concentrations used, and information regarding the source of antibodies is given in Supplemental Table 1 (Supplemental data for this article may be found on the American Journal of Physiology: Heart and Circulatory Physiology website.). The primary antibody-antigen reaction was detected using fluorescently labeled secondary antibody. An Olympus BX41 (Olympus America) equipped for epifluorescence microscopy was used for imaging, and images were recorded using a digital camera with MagnaFire 2.1 software.
Statistical analysis. All data were described as means Ϯ SE. To analyze the data statistically, we performed Student's t-test and MSCs, whereas PDE5A3 was absent (Fig. 1A) .
Tadalafil promoted MSC survival for extended duration. Tadalafil treatment showed no cytotoxicity on Tada MSCs as was evident from negligible LDH leakage (Fig. 1B) and minimal TUNEL positivity (Fig. 1, C and D) . Treatment with 100 M H 2 O 2 led to elevated LDH release (Fig. 1B) and higher TUNEL positivity (Fig. 1, C and D Fig. 1B ). These data were in agreement with the observed attenuated apoptosis in Tada MSCs (P Ͻ 0.01 vs.
Cont MSCs; Fig. 1, C and D) . The cytoprotective effects of one-time tadalafil treatment of MSCs persisted for 36 h, albeit with slow loss of cytoprotection over time (Fig. 1E) .
Cytoprotection with tadalafil involved cGMP/PKG1 activation. We observed increased cGMP activity in Tada MSCs in a dosedependent manner (Supplemental Fig. 1 ). Time-dependent cGMP activity assay revealed that cGMP enzyme activity increased significantly within 12 h after tadalafil treatment (P Ͻ 0.05; Fig. 2A ). However, cGMP activity declined over time until 36 h ( Fig. 2A) . In parallel with cGMP activity changes, PDE5A inhibition in Tada MSCs simultaneously increased PKG1 enzyme activity (P Ͻ 0.05; Fig. 2B ). PKG1 activity declined gradually over time, however, still remaining insignificantly higher at 36 h compared with Cont MSCs. The cytoprotection afforded by pretreatment of MSCs with tadalafil was abrogated in the presence of PKG1 inhibitor (1 M KT-5823). This was evident from the significantly higher leakage of LDH (Fig. 2C) as well as TUNEL positivity (Fig. 2D) Tada MSCs pretreated with the blockers were susceptible to cytotoxicity upon exposure to oxidant stress. These results signified the role of PKG1 in cytoprotection from tadalafil preconditioning of MSCs. Abrogation of the cytoprotective effects of tadalafil pretreatment of MSCs under oxidant stress was also observed by PKG1 inhibition using 20 nM K-252a (Supplemental Fig. 2, A-C) .
PKG1-shRNA abolished tadalafil-induced cytoprotection. Transduction efficiency of
Ad-PKG MSCs and Ad-Sc
MSCs was Ͼ90% (Fig. 2, E and F) . Successful knock down of PKG1 was observed in Ad-PKG MSCs at both gene and protein expression (P Ͻ 0.01; Fig. 2, G and H) . Tadalafil treatment effectively preserved the morphology of Ad-Sc MSCs compared with Ad-PKG MSCs, which were hypercontracted under oxidant stress (Fig. 2I) .
Ad-Sc MSCs exposed to 100 M H 2 O 2 without tadalafil pretreatment were used as positive controls (Fig. 2I) . LDH release from Ad-Sc MSCs treated with tadalafil was lower compared with Ad-PKG
MSCs and
Ad-Sc MSCs without tadalafil treatment (P Ͻ 0.01; Fig. 2J) .
Tadalafil promoted stem cell proliferation and postengraftment survival. Besides cytoprotection, another important effect of tadalafil on MSCs was increased cell proliferation, which was evident from higher BrdU uptake in Tada MSCs in vitro (P Ͻ 0.05; Fig. 3A ). For assessment of in vivo survival of the cells, Tada MSCs were transplanted in a rat heart model of acute myocardial infarction. The animals were killed at 2 and 4 days after engraftment in various treatment groups (Fig. 3B) . On both time points postengraftment, Tada MSCs transplanted immediately (2 h) after tadalafil treatment (group 2) showed improved survival in the infarcted heart compared with the nontreated Cont MSC transplanted group 1 (P Ͻ 0.01). Although survival of Tada MSCs decreased when transplanted 24 h after tadalafil treatment (group 3) compared with group 2, it was still higher compared with group 1. On the contrary, Tada MSCs injected 48 h after tadalafil treatment (group 4) showed poor survival compared with group 2 (P Ͼ 0.05). DMEM-injected female rat hearts (group 5) did not show sry gene expression. In addition, TUNEL positivity was reduced in the heart tissue in group 2 (P Ͻ 0.01 vs. group 1; Fig. 3C ). Immunohistological studies on day 4 after cell transplantation also showed a higher number of Ki67 ϩ cells in the infarcted heart at the site of the cell graft in group 2 (n ϭ 3 animals/ group) compared with group 1 (P Ͻ 0.01; Fig. 3D ). However, no significant presence of proliferating cells was observed in either group 2 and group 3 animal hearts 4 wk after their respective treatment as was evident from the absence of Ki67 ϩ donor cells in the cell-transplanted areas (data not shown).
Tada MSCs induce angiomyogenesis in the infarcted heart. Fluorescence immunostaining specific for cardiac proteins was carried out to visualize residual muscle fibers that survived over the period of time in the infarct and peri-infarct regions besides elucidation of myogenic differentiation of the transplanted cells in group 2 and group 1. Immunostaining of histological sections with desmin-specific antibody showed extensive presence of desmin-positive myocytes in the center of the infarct in group 2 animal hearts (Fig. 4, A-D) compared with group 1 (Fig. 4, D-F) . Parts B and C of Fig. 4 are the magnified images from the center of the infarct in Fig. 4A to show the areas of residual myocardium and the neofibers, Fig. 4 . Transplantation of Tada MSCs was cardioprotective and enhanced angiogenesis in the infarcted heart. A-G: fluorescence immunostaining of histological tissue sections for desmin expression to visualize residual myocardium and myogenic activity in the infarcted heart. B and C are the magnified images of the selected areas in the center of the infarct from A to show residual myocardium and neofibers, respectively, in group 2 animal hearts, which was markedly more compared with group 1 animal hearts, as was evident from magnified images in Fig. 2, F and G, from Fig. 2E , respectively. DAPI (blue) was used to visualize the nuclei (Original magnification ϭ ϫ400). D: histological sections from group 2 animal hearts immunostained for desmin (red) and green fluorescent protein (GFP; green) to show that the transplanted Tada MSCs differentiated into neofibers. DAPI staining was used to visualize nuclei (original magnification ϭ ϫ40). H: double-fluorescence immunostaining of histological sections from group 1 and group 2 animal hearts for von Willebrand (vW) Factor VIII (red) and smooth muscle actin (green). The nuclei were visualized by staining with DAPI (blue). Blood vessel density (at 200ϫ) was significantly higher in both infarct as well as peri-infarct regions in Tada MSC-transplanted group 2 animal hearts compared with the Cont MSC-transplanted group 1 (P Ͻ 001 in both infarct and peri-infarct regions).
respectively. To show the neofibers originated from the donor Tada MSCs, double-fluorescence immunostaining of the histological sections for desmin (red) and green fluorescent protein (GFP; green) expression was carried out (Fig. 4D) . The results showed that transplanted Tada MSCs differentiated into neofibers as was evident from colocalization of GFP (green) with desmin (red). Staining with DAPI (blue) was performed for visualization of the nuclei. On the contrary, Fig. 4 , F and G, represents the magnified images of selected areas in Fig. 4E from group 1 (control), which showed markedly less residual myocardium and low neomyogenic activity.
Tada MSC-transplanted animals also showed extensive angiogenic response, especially in the peri-infarct region (Fig. 4H ). Blood vessel density (200ϫ) in Tada MSC-treated group 2 was (116 Ϯ 11 and 56 Ϯ 7) in the infarct and peri-infarct regions compared with group 1 (71 Ϯ 5 and 44 Ϯ 4). Infarct size was significantly attenuated in group 2 animal hearts compared with group 1 (P ϭ 0.022; Fig. 5A) .
Transplantation of Tada
MSCs improved global heart function. Transthoracic echocardiography showed that the indexes of LV heart function, including left ventricle ejection fraction and left ventricle fractional shortening, were significantly preserved in Tada MSC-transplanted group 2 (55.7 Ϯ 2 and 24.1 Ϯ 1.5%) compared with the nontreated native Cont MSC-transplanted group 1 (47 Ϯ 2.5%, P Ͻ 0.01; 18.8 Ϯ 2%, P Ͻ 0.04) (Fig.  5B) . Moreover, the left ventricle end-diastolic (7.1 Ϯ 0.2 mm) and left ventricle end systolic (5.4 Ϯ 0.2 mm) dimensions were lower in group 2 compared with group 1 (7.8 Ϯ 0.2 mm, P Ͻ 0.02 and 6.34 Ϯ 0.3, P Ͻ 0.01), thus indicating better preservation of LV contractile function (Fig. 5C ).
DISCUSSION
The important finding of our study is that pharmacological manipulation of MSCs with tadalafil protected the cells for up to 36 h against a subsequent oxidant stress and promoted their proliferative potential. Moreover, transplantation studies in an experimental model of acute myocardial infarction revealed extensive survival of Tada MSCs during the acute phase and extensive angiomyogenic response 4 wk after transplantation.
Activation of cGMP is involved in various physiological processes and fate determination of stem cells (11, 28) . Therefore, the strategy of PDE inhibition may be exceedingly significant, since many cellular functions, ranging from mobilization of stem cells into peripheral circulation to differentiation, can be regulated by using PDE inhibitors via activation of cGMP and cAMP (6, 20, 26) . Despite these interesting observations, little is known about the distribution of PDE5A in stem and progenitor cells and also regarding the use of PDE5A inhibitors in relation to their survival and proliferation. PDE5A has wide distribution in body tissues and cells wherein it exists in three isoforms, namely PDE5A1, PDE5A2, and PDE5A3, which only differ in their NH 2 -terminal sequence (14) . Whereas PDE5A1 and PDE5A2 are ubiquitous, distribution of PDE5A3 is more restricted to smooth muscle. Our results are in agreement with the previously published data from other researchers and showed that PDE5A2 isoform expression was predominant in the cultured MSCs. Abundant presence of PDE in native MSCs therefore provides an excellent target for tadalafil to activate cGMP/PKG signaling with the resultant cytoprotective effects that were sensitive to PKG inhibition with specific inhibitors and PKG-specific shRNA. Previous studies have also shown that activation of cGMP had prosurvival and proproliferative effects on stem cells (15, 19) . Although the exact mechanism of the proproliferative effects of cGMP is multifactorial, it is generally considered to activate resting cells into reproductive cycle and promotes DNA synthesis (19) . Furthermore, activation of the phosphatidylinositol 3-kinase/Akt pathway has been implicated as a mediator of the cGMP activity-associated increase in cell proliferation (26) . More importantly, the cytoprotective effects of one-time treatment of the cells with tadalafil were extended to at least 36 h after treatment. We have already shown in vivo that repeated administration of tadalafil at regular intervals of 48 h extended the cardioprotective effects of tadalafil treatment (2) . In the light of these results, our present study extrapolated the prolonged prosurvival and proproliferative effects of tadalafil in MSCs via cGMP/PKG signaling.
Although having selective inhibitory effects on PDE5 activity, sildenafil and vardenafil differ from tadalafil in their interaction with the catalytic domain of PDE5, which forms the basis of their difference in affinity and effectiveness (25) . Moreover, unlike sildenafil and vardenafil with 4 h biological half-life, tadalafil is a long-acting PDE5A inhibitor with 17.5 h biological half-life. Notwithstanding a longer biological halflife, tadalafil is clinically safe, well-tolerated, and remains therapeutically effective for 36 -48 h (21) . Besides, tadalafil has more specificity for PDE5 and shows faster onset of action, which is sustained over prolonged time compared with sildenafil. The cytokine-rich hostile microenvironment of the infarcted heart, extensively infiltrated by the immune cells and aggravated by the lack of oxygen and nutrients, is a big challenge for stem cells for their survival during the acute phase after myocardial infarction. Therefore, a longer window of cytoprotection will allow more time for the transplanted cells to acclimate in the unfavorable microenvironment of the infarcted myocardium, thus ensuring better survival and engraftment of transplanted cells. The choice for acute-phase delivery of the stem cells was deliberate and was meant to assess the cytoprotective effects of tadalafil treatment in a harsh microenvironment and subsequently study the functional benefits of the surviving cells on the infarcted heart. Therefore, we anticipated from our results that chronic-phase transplantation of tadalafil-treated cells would be even better in terms of survival and engraftment. Tada MSC engraftment subsequently supported a significant angiomyogenic response and protection of the ischemic myocardium, thus resulting in attenuated infarct size and preservation of the indexes of LV contractile function. Besides these advantages, with tadalafil being a clinically tested drug and already in use for oral treatment of patients with erectile dysfunction (22) , use of tadalafil for priming of stem cells before transplantation provides a simple, safe, and clinically relevant option to enhance their survival. We therefore conclude that tadalafil may be identified for a potential therapeutic application in stem cell-based therapy of the heart. Study limitations. Despite encouraging results, the present study is not without limitations. First, in-depth studies would be required to elucidate the downstream signaling subsequent to cGMP/PKG activation that is responsible for improved survival of Tada MSCs under oxidant stress and in the ischemic myocardium. Although transplantation of Tada MSCs led to a significant angiomyogenic response, regional blood flow changes to assess the functional status of the newly formed vascular structures and assessment of the myogenic response at a Ͼ4-wk time point would be required to assess the factual contribution of angiomyogenesis in the therapeutic benefits of this novel treatment approach. Furthermore, characterization of Tada MSCs for paracrine activity would provide an understanding of the mechanism of enhanced angiomyogenic response in the infarcted myocardium.
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